Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $23.1900 (2.43%) ($22.7700 - $23.2500) on Thu. May. 16, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.78% (three month average) | RSI | 33 | Latest Price | $23.1900(2.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(60%) XBI(59%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -1.89% in a week (0% probabilities). VXX(-18%) VIXM(-8%) UUP(-6%) TLT(-4%) IFRA(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.89% (StdDev 3.78%) | Hourly BBV | 0 () | Intraday Trend | 1.7% | | | |
|
1 - 5 Day Possible Target | $11.21(-51.66%) | Resistance Level | $24.92 | 5 Day Moving Average | $23.01(0.78%) | 10 Day Moving Average | $23.97(-3.25%) | 20 Day Moving Average | $24.92(-6.94%) | To recent high | -16.5% | To recent low | 17.5% | Market Cap | $1.44b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |